Illumina, the world’s largest DNA sequencing company, cut its sales forecast for 2023 as demand slumped in China, and also announced that two executives will depart.
In quarterly results released today, the San Diego-based company recorded $1.18 billion in revenue. It expects a 1% increase in revenue in 2023, revising down a 7% to 10% growth…
This story from endpts.com was posted on 2023-08-10 by @arcticc.